In short. Cannula choice, slow injection and declining a high-risk area, none of which removes the risk of a vascular event either.
Key points
- Every measure described here lowers the chance of a vascular event.
- None of them eliminates it, and none of them, including imaging, makes an injection free of risk.
- A description that implies otherwise is describing a procedure that does not exist.
Risk in aesthetic injection can be reduced in several ways, and each of them has a limit. Presenting them together, with the limits attached, is more useful than presenting any one of them as the answer.
Declining the treatment
This is the most effective option and the least discussed. A procedure with a rare but serious complication is one a person is entitled to decide against, and no reason beyond that is required. Where the concern being treated is minor and the risk being accepted is not, declining is a proportionate decision rather than an avoidance of one.
Instrument choice
A blunt-tipped cannula tends to push structures aside rather than pierce them, which makes entering a vessel less likely than with a sharp needle. That reasoning is sound and the practice is widespread. Its limits are real: a blunt tip does not make entry impossible, a cannula is not suitable for every site, every material or every plane, and the choice is a clinical one rather than a rule.
Risk reduced is not risk removed
Every measure described here lowers the chance of a vascular event. None of them eliminates it, and none of them, including imaging, makes an injection free of risk. A description that implies otherwise is describing a procedure that does not exist.
Technique
Injecting slowly and at low pressure limits how much material can be delivered into a vessel if one is entered, which is why the practices are taught. Aspirating before injecting is widely recommended and its reliability is debated, because a negative result does not prove the tip is outside a vessel. Using a smaller volume in a single pass reduces the amount that could be misplaced. None of these measures prevents entry; they reduce the consequence if it occurs.
Site selection
Some areas carry a higher risk than others because of the vessels that run through them. Choosing a different site, or a different approach to the same site, changes the risk rather than removing it. Declining a high-risk area altogether is a legitimate clinical decision, and it is one of the most useful conversations a service can have with a person before treatment.
Where a scan fits
Beside these measures rather than above them. It provides information about one person’s anatomy, which informs the decisions above, and it does not make any of them unnecessary. The measures that reduce risk most reliably are decisions rather than devices: what to use, how fast to inject, where to inject, and whether to inject at all.
Know these before you need them
- Pain out of proportion to the procedure, or pain that is worsening rather than settling.
- Blanching, dusky discolouration or blistering of the skin in the treated area.
- Any change in vision, or severe pain behind the eye — seek emergency care immediately.
Knowing the signs matters more than knowing the equipment, because the signs are what you can act on and they are the reason the risk is taken seriously in the first place.
Frequently asked questions
What actually reduces the risk of a vascular event?
Several things reduce it without removing it: a blunt-tipped cannula rather than a sharp needle, slow injection at low pressure, avoiding a site judged high risk, using a smaller volume, and declining a treatment that is not needed. Each has its own limits and none is a guarantee.
Is a cannula safer than a needle?
A blunt tip tends to push structures aside rather than pierce them, which makes entering a vessel less likely. It does not make it impossible, a cannula is not suitable for every site or material, and no instrument removes the risk. The advantage is real and it is relative.
Is it reasonable to decline a treatment?
It is one of the most effective options available. A rare complication that would be serious is a legitimate reason to decide against a procedure, and no justification beyond that is required. Declining is a decision rather than a gap in the plan.
Risks & Limitations
- A vascular occlusion is a rare but serious emergency; it can occur during an injection and no scan or technique removes the risk.
- Showing where a vessel runs does not prevent material entering it, because the risk arises while the needle is in the tissue.
- No comparative study has shown that routine scanning reduces how often vascular events happen.
- A normal-looking scan means a vessel was not identified at that plane and resolution, not that none is present.
- Imaging shows structure; it does not dissolve or reverse an occlusion, and it is not a treatment.
When to Seek Care
- Pain out of proportion to the procedure, or pain that is worsening rather than settling — seek emergency assessment immediately.
- Blanching, dusky discolouration or blistering of the skin in the treated area.
- Any change in vision, or severe pain behind the eye — this is an emergency, not an appointment.
- Contact the service that holds your records for anything else, rather than relying on a website.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — cleared diagnostic ultrasound devices and their indications
- European Medicines Agency (EMA) and national regulators — dermal filler safety communications
- National Medical Products Administration (NMPA, China) — approved injectable products and their indications
- National Institute for Health and Care Excellence (NICE, UK) — guidance on diagnostic imaging
- Cochrane Library — systematic reviews of ultrasound guidance for vascular access and injection
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.